Angiogenesis: New aspects relating to its initiation and control

APMIS

Volumn 105, Issue 6, 1997, Pages 417-437

  Norrby, Klas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Control; Initiation

Indexed keywords

ANGIOGENESIS; CANCER GROWTH; CANCER RESEARCH; EXTRACELLULAR MATRIX; GENE THERAPY; HUMAN; HYPOXIA; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; REVIEW; WOUND HEALING;

EID: 0030806436     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb00590.x     Document Type: Review

References (165)

1. Alessandro, R., Masiero, L., Liotta, L. A. & Kohn, E. C.: The role of calcium in the regulation of invasion and angiogenesis. In Vivo 10: 153-160, 1996.
2. Andrade, S. P., Fan, T.-P. D. & Kewis, G. P.: Quantitative in-vivo studies on angiogenesis in a rat sponge model. Br. J. Exp. Pathol. 68: 755-766, 1987.
3. Arbiser, J. L.: Angiogenesis and the skin: A primer. J. Am. Acad. Dermatol. 34: 486-497, 1996.
4. Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F. & Isner, J. M.: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92 (Suppl. II): II-365-II-371, 1995.
5. Auerbach, W. & Auerbach, R.: Angiogenesis inhibition: A review. Pharmacol. Ther. 63: 265-311, 1994.
6. Auerbach, R., Kubal, L., Knighton, D. & Folkman, J.: A simple procedure for the long-term cultivation of chicken embryos. Dev. Biol. 41: 391-394, 1974.
7. Auerbach, R., Auerbach, W. & Polakowski, I.: Assays for angiogenesis: A review. Pharmacol. Ther. 51: 1-11, 1991.
8. Axelsson, K., Ljung, B.-M. E., More II, D. H., Thor, A. D., Chew, K. L., Edgerton, S. M., Smith, H. S. & Mayall, B. H.: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer. Inst. 87: 997-1007, 1995.
9. Banai, S., Shweiki, D., Pinson, A., Chandra, M., Lazarovici, G. & Keshet, E.: Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc. Res. 28: 1176-1179, 1994.
10. Bashkin, P., Razin, E., Eldor, A. & Vlodavsky, I.: Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood 75: 2204-2212, 1990.
11. Bischoff, J.: Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell. Biol. 5: 69-74, 1995.
12. Bornstein, P. & Sage, E. H.: Thrombospondins. Methods Enzymol. 245: 62-85, 1994.
13. Bouck, N.: Tumor angiogenesis: The role of oncogenes and tumor suppressor genes. Cancer Cells 2: 179-185, 1990.
14. Brogi, E., Wu, T., Namiki, A. & Isner, J. M.: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649-652, 1994.
15. Cendan, J. C, Souba, W. W., Copeland, E. M. 3rd & Lind, D. S.: Cytokines regulate endotoxin stimulation of endothelial cell arginine transport. Surgery 117: 213-219, 1995.
16. Christenson, L. K. & Stouffer, R. L.: Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. Endocrinology 137: 367-374, 1996.
17. Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T. & Stern, D.: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172: 1535-1545, 1990.
18. Clinton, M., Long, W. F., Williamson, F. B., Duncan, J. I. & Thompson, W. D.: Effect of the mast cell activator compound 48/80 and heparin on angiogenesis in the chick chorioallantoic membrane. Int. J. Microcirc. 7: 315-326, 1988.
19. Cockerill, G. W., Gamble, J. R. & Vadas, M. A.: Angiogenesis: Models and modulators. Int. Rev. Cytol. 159: 113-160, 1995.
20. Connally, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M. & Feder, J.: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84: 1470-1478, 1989.
21. Conrad, T. J., Chandler, D. B., Corless, J. M. & Klintworth, G. K.: In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis. Lab. Invest. 70: 426-434, 1994.
22. Contrino, J., Hair, G., Kreutzer, D. L. & Rickles, F. R.: In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nature Medicine 2: 209-215, 1996.
23. D'Amato, R. J., Longhnan, M. S., Flynn, E. & Folkman, J.: Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. 91: 4082-4085, 1994.
24. Dameron, K. M., Volpert, O. V., Tainsky, M. A. & Bouck, N.: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584, 1994.
25. Denekamp, J.: Vasculature as a target for tumour therapy. Prog. Appl. Microcirc. 4: 28-38, 1984.
26. Dethlefsen, S. M., Matsuura, N. & Zetter, B. R.: Mast cell accumulation at sites of tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis 14: 395-408, 1994.
27. Detmar, M., Tenorio, S., Hettmannsperger, U., Ruszczak, Z. & Orfanos, C. E.: Cytokine regulation of proliferation and ICAM1 expression of human dermal microvascular endothelial cells in vitro. J. Invest. Dermatol. 98: 147-153, 1992.
28. Duncan, J. I., Brown, F. I., McKinnon, A., Long, W. F., Williamson, F. B. & Thompson, W. D.: Patterns of angiogenesis response to mast cell granule constituents. Int. J. Microcirc. 11: 21-33, 1992.
29. Dvorak, H. F., Harvey, V. S., Estrella, P., Brown, L. F., McDonagh, J. & Dvorak, A. M.: Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest. 57: 673-686, 1987.
30. Dvorak, H. F., Brown, L. F., Detmar, M. & Dvorak, A. M.: Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146: 1029-1039, 1995.
31. Editorial. J. Natl. Cancer. Inst. 88: 786-788, 1996.
32. Egginton, S., Hudlicka, O., Brown, M. D., Graciotti, L. & Granata, A. L.: In vivo pericyte-endothelial cell interaction during angiogenesis in adult cardiac and skeletal muscle. Microvasc. Res. 51:, 213-228, 1996.
33. Ellis, L. M. & Fidler, I. J.: Angiogenesis and breast cancer. Lancet 346: 388-390, 1995.
34. Endo, Y., Nakamura, M., Nitta, Y. & Kumagai, K.: Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor. Br. J. Pharmacol. 114: 187-193, 1995.
35. Fajardo, L. F., Kowalski, J., Kwan, H. H., Prionas, S. D. & Allison, A. C.: The disc angiogenesis system. Lab. Invest. 58: 718-724, 1988.
36. Fajardo, L. F., Prionas, S. D., Kwan, H. H., Kowalski, J. & Allison, A. C.: Transforming growth factor β1 induces angiogenesis in vivo with a threshold pattern. Lab. Invest. 74: 600-608, 1996.
37. Falcone, D. J., McCaffrey, T. A., Halmovitz-Friedman, A. & Garcia, M.: Transforming growth factor β1 stimulated macrophage urokinase expression and release of matrix bound basic fibroblast growth factor. J. Cell. Physiol. 155: 595-605, 1993.
38. 1 or interleukin-1 receptor antagonists. Br. J. Pharmacol. 110: 43-49, 1993.
39. Ferrara, N. & Henzel, W. J.: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851-858, 1989.
40. Ferrara, N., Houck, K., Jakeman, L. & Leung, D.: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13: 18-32, 1992.
41. Folkman, J.: Tumor angiogenesis. In: Mendelsohn, J., Howley, P. M., Israel, M. A. & Liotta, L. A. (Eds.): The molecular basis of cancer. WB Saunders, Philadelphia, pp. 206-232, 1995.
42. Folkman, J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1: 27-31, 1995.
43. Folkman, J.: Clinical applications of research on angiogenesis. N. Engl. J. Med. 333: 1757-1763, 1995.
44. Folkman, J.: Tumor angiogenesis and tissue factor. Nature Medicine 2: 167-168, 1996.
45. Folkman, J., Long, D. M. & Becker, F. F.: Growth and metastasis of tumor in organ culture. Cancer 16: 453-467, 1963.
46. Folkman, J., Cole, P. & Zimmerman, S.: Tumor behavior in isolated perfused organs: In vitro growth and metastasis of biopsy material in rabbit and canine intestinal segment. Ann. Surg. 164: 491-503, 1966.
47. Folkman, J., Merler, E., Abernathy, C. & Williams, G.: Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133: 275-288, 1971.
48. Fràter-Schröder, M., Risau, W., Hallmann, R. & Gautschi, P.: Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. 84: 5277-5281, 1987.
49. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A. & Cheresh, D. A.: Definition of two angiogenic pathways by distinct av integrins. Science 270: 1500-1502, 1995.
50. Galli, S. J. & Wershil, B. K.: Mouse mast cell cytokine production: role in cutaneous inflammatory and immunological responses. Exp. Dermatol. 4: 240-249, 1995.
51. Galli, S. J., Tsai, M., Wershil, B. K., Iemura, A., Ando, A., Tam, S.-Y. & Costa, J. J.: The effects of stem cell factor, the ligand for the c-kit receptor, on mouse and human mast cell development, survival, and function. In: Kitamura, Y., Yamamoto, S., Galli, S. J. & Greaves, K. W. (Eds): Biological and molecular aspects of mast cell and basophil differentiation and function. Raven Press, New York. 1995, pp. 1-11.
52. Giatromanolaki, A., Koukourakis, M., O'Byrne, K., Fox, S., Whitehouse, R., Talbot, D. C., Harris, A. L. & Gatter, K. C.: Prognostic value of angiogenesis in operable non-small cell lung cancer. J. Pathol. 179: 80-88, 1996.
53. Gimbrone, M. A. Jr., Cotran, R. A., Leapman, S. B. & Folkman, J.: Tumor growth and neovascularization: An experimental model using the rabbit cornea. J. Natl. Cancer Inst. 52, 413-427, 1974.
54. Gordon, R. J., Burd, P. R. & Galli, S. J.: Mast cells as a source of multifunctional cytokines. Immunol. Today 11: 458-464, 1990.
55. Gospodarowicz, D., Abraham, J. A. & Schilling, J.: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. 86: 7311-7315, 1989.
56. Green, D., Hull, R. D., Brant, R. & Pineo, G. F.: Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet 339: 1476, 1992.
57. Gruber, B. L., Marchese, M. J. & Kew, R. R.: Transforming growth factor-β1 mediates mast cell chemotaxis. J. Immunol. 152: 5860-5867, 1994.
58. Gullino, P. M.: Prostaglandins and gangliosides of tumor microenvironment: Their role in angiogenesis. Acta Oncol. 34: 439-441, 1995.
59. Harada, K., Friedman, M., Lopez, J. J., Wang, S. Y., Li, J., Prasad, P. V., Pearlman, J. D., Edelman, E. R., Sellke, F. W. & Simons, M.: Vascular endothelial growth factor administration in chronic myocardial ischemia. Am. J. Physiol. 270: H1791-H1802, 1996.
60. Harvima, R. J. & Schwartz, L. B.: Mast cell-derived mediators. In: Foreman, J. C. (Ed.): Immunopharmacology of mast cells and basophils. Academic Press, London, 1993, pp. 115-138.
61. Hauser, S. & Weich, H. A.: A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9: 259-268, 1993.
62. Hellerqvist, C. G., Thurman, G. B., Page, D. L., Wang, Y.-F., Russell, B. A., Montgomery, C. A. & Sundell, H. W.: Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B β-hemolytic streptococcus. J. Cancer Res. Oncol. 120: 63-70, 1993.
63. Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C. & Klagsbrun, M.: A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251: 936-939, 1991.
64. Holmgren, L.: Antiangiogenesis restricted tumor dormancy. Cancer Metast. Rev. 15: 241-245, 1996.
65. 9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats. Br. J. Pharmacol. 109: 14-17, 1993.
66. Hu, D.-E. & Fan, T.-P. D.: Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br. J. Pharmacol. 114: 262-268, 1995.
67. Hu, D.-E., Hori, Y. & Fan, T.-P.: Interleukin-8 stimulates angiogenesis in rats. Inflammation 17, 135-143, 1993.
68. Hu, D.-E., Hori, Y., Presta, M., Gresham, G. A. & Fan, T. P.: Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation 18: 45-58, 1994.
69. Ionov, I. D.: Inhibition of mast cell activity as a new approach to anti-cancer therapy. Int. J. Radiat. Biol. 60: 287-291, 1991.
70. 165 in patient with ischaemic limb. Lancet 348: 370-374, 1996.
71. Jakobson, A. E.: Angiogenesis induced by mast cell secretion in rat peritoneal connective tissue is a process of three phases. Microvasc. Res. 47: 252-269, 1994.
72. Jendraschak, E. & Sage, E. H.: Regulation of angiogenesis by SPARC and angiostatin: Implications for tumor cell biology. Cancer Biol. 7: 139-146, 1996.
73. Kirchner, L. M., Schmidt, S. P. & Gruber, B. S.: Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis. Microvasc. Res. 51: 2-14, 1996.
74. Klagsburn, M.: Mediators of angiogenesis: The biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Cancer Biol. 3: 81-87, 1992.
75. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G. & Strieter, R. M.: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
76. Kooy, J., Taylor, N. H., Healy, D. L. & Rogers, P. A.: Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation. Hum. Reprod. 11: 1067-1072, 1996.
77. Lantz, M., Thysell, H., Nilsson, E. & Olsson, I.: On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J. Clin. Invest. 88: 2026-2031, 1991.
78. Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V. & Nuseir, N.: Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 329: 630-632, 1987.
79. Leung, D. W, Cachianes, G., Kuang, W. J., Goeddel, D. V. & Ferrara, N.: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
80. Li, J., Perrella, M. A., Tsai, J.-C., Yet, S.-F., Hsieh, C.-M., Yoshizumi, M., Patterson, C., Endege, W. O., Zhou, F. & Lee, M.-E.: Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem. 270: 308-312, 1995.
81. Lukacs, N. W., Kunkel, S. L., Strieter, R. M., Evanoff, H. L., Kunkel, R. G., Key, M. L. & Taub, D. D.: The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. Blood 87: 2262-2268, 1996.
82. Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P. & Persico, M. G.: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. 88: 9267-9271, 1991.
83. Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, K., Del Vecchio, S., Lei, K.-J. L., Chou, J. Y. & Persico, M. G.: Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14. Oncogene 8: 925-931, 1993.
84. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F. & Sharpe, R. J.: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247: 77-79, 1990.
85. Mainoe, T. E., Gray, G. S., Hunt, A. J. & Sharpe, R. J.: Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51: 2077-2083, 1991.
86. Meininger, C. J., Yano, H., Rottapel, R., Bernstein, A., Zsebo, K. M. & Zetter, B. R.: The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79: 958-963, 1992.
87. Meininger, C. L., Brightman, S. E., Kelly, K. A. & Zetter, B. R.: Increased stem cell factor release by hemangioma-derived endothelial cells. Lab. Invest. 72: 166-173, 1995.
88. Minchenko, A., Salceda, S., Bauer, T. & Caro, J.: Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res. 40: 35-39, 1994.
89. Modlich, U., Kaup, F.-J. & Augustin, H. G.: Cyclic angiogenesis and blood vessel regression in the ovary: Blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab. Invest. 74: 771-780, 1996.
90. Montrucchio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolono, F., Emanuelli, G. & Camussi, G.: Tumor necrosis factor-alpha-induced angiogenesis depends on in situ platelet activating factor biosynthesis. J. Exp. Med. 180: 377-382, 1994.
91. Morandi, V., Cherradi, S.-E. L., Lambert, S., Fauvel-Lafève, F., Legrand, Y. J. & Legrand, C.: Proinflammatory cytokines (interleukin-1β and tumor necrosis factor-alpha) downregulate synthesis and secretion of thrombospondin by human endothelial cells. J. Cell. Physiol. 160: 367-377, 1994.
92. Moses, M. A., Sudhalter, J. & Langer, R.: Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408-1411, 1990.
93. Nelson, R. M., Venot, A. & Bevilacqua, M. P.: Carbohydrate-protein interactions in vascular biology. Annu. Rev. Cell. Dev. Biol. 11: 601-631, 1995.
94. Neufeld, G., Cohen, T., Gitay-Goren, H., Poltorak, Z., Tessler, S., Sharon, R., Gengrinovitch, S. & Levi, B.-Z.: Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metast. Rev. 15: 153-158, 1996.
95. Nickoloff, B. J., Mitra, R. S., Varani, J., Dixit, V. M. & Polverini, P. J.: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol. 144: 820-828, 1994.
96. Norrby, K.: Cyclosporine is angiostatic. Experientia 48: 1135-1138, 1992.
97. Norrby, K.: Heparin and angiogenesis: A low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically. Haemostasis 23: (Suppl. 1), 141-149, 1993.
98. Norrby, K.: Basic fibroblast growth factor and de novo mammalian angiogenesis. Microvasc. Res. 48: 96-113, 1994.
99. Norrby, K.: Evidence of specificity in the action of angiogenesis antagonists. Int. J. Microcirc. 14: 226-232, 1994.
100. Norrby, K.: Evidence of a dual role of endogenous histamine in angiogenesis. Int. J. Exp. Pathol. 76: 87-92, 1995.
101. Norrby, K.: VEGF Vascular endothelial growth factor and de novo mammalian angiogenesis. Microvasc. Res. 57: 154-163, 1996.
102. Norrby, K.: TNF-alpha and de novo mammalian angiogenesis. Microvasc. Res. 52: 79-83, 1996.
103. Norrby, K.: Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif. 29: 315-323, 1996.
104. Norrby, K.: Mast cells and de novo angiogenesis: Angiogenic capability of individual mast-cell mediators such as histamine, TNF, IL-8 and bFGF. In press. Inflamm. Res. 1997.
105. Norrby, K. & Sörbo, J.: Heparin enhances angiogenesis by a systemic mode of action. Int. J. Exp. Pathol. 73: 147-155, 1992.
106. Norrby, K. & Woolley, D.: Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumour tissue. Adv. Biosci. 89: 71-115, 1993.
107. Norrby, K. & Østergaard, P.: Basic-fibroblast-growth-factor-mediated de novo angiogenesis is more effectively suppressed by low-molecular-weight than by high-molecular-weight heparin. Int. J. Microcirc. 16: 8-15, 1996.
108. Norrby, K., Jakobsson, A. & Sörbo, J.: Mast-cell-mediated angiogenesis: A novel experimental model using the rat mesentery. Virchows Arch. [Cell Pathol.] 52: 195-206, 1986.
109. Norrby, K., Jakobsson, A. & Sörbo, J.: Age-dependent mast-cell-mediated angiogenesis. APMIS 96: (Suppl 2), 251-261, 1988.
110. Norrby, K., Jakobsson, A. & Sörbo, J.: Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Arch. [Cell Pathol.] 57: 251-256, 1989.
111. Norrby, K., Jakobsson, A. & Sörbo, J.: Quantitative angiogenesis in spreads of intact rat mesenteric windows. Microvasc. Res. 39: 341-348, 1990.
112. Norrby, K., Bani, D., Bigazzi, M. & Bani Sacchi, T.: Relaxin, a potent microcirculatory effector, is not angiogenic. Int. J. Microcirc. 16: 227-231, 1996.
113. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. & Folkman, J.: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
114. O'Shea, K. S. & Dixit, V. M.: Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J. Cell. Biol. 107: 2737-2748, 1988.
115. Paleolog, E. M., Delasalle, S.-A. J., Buurman, W. A. & Feldman, M.: Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood 84: 2578-2590, 1994.
116. Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J. & Hanahan, D.: Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. 93: 2002-2007, 1996.
117. Patan, S., Haenni, B. & Burri, P. H.: Evidence for intussusceptive capillary growth in the chicken chorio-allantoic membrane (CAM). Anat. Embryol. 187: 121-130, 1993.
118. Petzelbauer, P., Watson, C. A., Pfau, S. E. & Pober, J. S.: IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 7: 267-272, 1995.
119. Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D. & Risau, W.: Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer 59: 520-529, 1994.
120. Polverini, P. J.: The pathophysiology of angiogenesis. Crit. Rev. Oral. Biol. Med. 6: 230-247, 1995.
121. Polverini, P. J.: Cellular adhesion molecules. Newly identified mediators of angiogenesis. Am. J. Pathol. 148: 1023-1029, 1996.
122. Qu, Z., Huang, X.-N., Ahmadi, P., Andresevic, J., Planck, S. R., Hart, C. E. & Rosenbaum, J. T.: Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab. Invest. 73: 339-346, 1995.
123. Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marmé, D. & Kerbel, R. S.: Oncogenes as inducers of tumor angiogenesis. Cancer Metast. Rev. 14: 263-277, 1995.
124. Reed, J. A., Albino, A. P. & McNutt, N. S.: Human cutaneous mast cells express basic fibroblast growth factor. Lab. Invest. 72: 215-222, 1995.
125. Ribatti, D., Vacca, A., Schiraldi, G., Sorino, S., Caprio, F., Mazzotta, F., Roncali, L. & Bonifazi, E.: Pyogenic granuloma stimulates angiogenesis in the chick embryo chorioallantoic membrane. Int. J. Microcirc. 16: 82-88, 1996.
126. Risau, W.: Differentiation of endothelium. FASEB J. 9: 926-933, 1995.
127. Risau, W.: What, if anything, is an angiogenic factor? Cancer Metast. Rev. 15: 149-151, 1996.
128. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H. & Fauci, A. S.: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. 83: 4167-4171, 1986.
129. Roche, W. R.: The nature and significance of tumour-associated mast cells. J. Pathol. 148: 175-182, 1986.
130. Rusnati, M. & Presta, M.: Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int. J. Clin. Lab. Res. 26: 15-23, 1996.
131. Salvén, P., Joensuu, H., Heikkilä, P., Matikainen, M.-T., Wasenius, V.-M., Alanko, A. & Alitalo, K.: Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br. J. Cancer 74: 69-12, 1996.
132. Saltzman, A. K., Olson, T. A., Mohanraj, D., Carson, L. E. & Ramakrishnan, S.: Prevention of postoperative adhesions by an antibody to vascular permeability/vascular endothelial growth factor in a murine model. Am. J. Obstet. Gynecol. 174: 1502-1506, 1996.
133. Senger, D. R., Van De Water, L., Brown, L. F., Nagy, J. A., Yeo, K.-T., Yeo, T.-K., Berse, B., Jackman, R. W., Dvorak, A. M. & Dvorak, H. F.: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metast. Rev. 12: 303-324, 1993.
134. Shifren, J. L., Doldi, N., Ferrara, N., Mesiano, S. & Jaffe, R. B.: In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J. Clin. Endocrinol. Metab. 79: 316-322, 1994.
135. Sorgente, N., Kuettner, K. E., Sobel, L. W. & Eisenstein, R.: The resistance of certain tissues to invasion. II. Evidence of extractable factors in cartilage which inhibit invasion by vascularized mesenchyme. Lab. Invest. 32: 217-222, 1975.
136. Sörbo, J. & Norrby, K.: Mast-cell histamine expands the microvasculature spatially. Agents Actions SCI, C387-C389, 1992.
137. 2. Int. J. Exp. Pathol. 75: 43-50, 1994.
138. Srivastava, A., Laidler, P., Davies, R. P., Morgan, K. & Hughes, L. E.: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am. J. Pathol. 133: 419-423, 1988.
139. v mice exhibit a decreased rate of tumor angiogenesis. Int. J. Cancer 42: 48-52, 1988.
140. Strieter, R. M., Kunkel, S. L., Elner, V. M., Martonyi, C. L., Koch, A. E., Polverini, P. J. & Elner, S. G.: Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141: 1279-1284, 1992.
141. Sunderkötter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. & Sorg, C.: Macrophages and angiogenesis. J. Leukoc. Biol. 55: 410-422, 1994.
142. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S. & Nose, T.: Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56: 2185-2190, 1996.
143. Taylor, S. & Folkman, J.: Protamine is an inhibitor of angiogenesis. Nature 297: 307-312, 1982.
144. Teicher, B. A., Holden, S. A., Dupuis, N. P., Kakeji, Y., Ikebe, M., Emi, Y. & Goff, D.: Potentiation of cytotoxic therapies by TNP-470 and minocyline in mice bearing EMT-6 mammary carcinoma. Breast Cancer Res. Treat. 36: 227-236, 1995.
145. Thorpe, P. E., Derbyshire, E. J., Andrade, S. P., Press, N., Knowles, P. P., King, S., Watson, G. J., Yang, Y.-C. & Rao-Betté, M.: Heparin-steroid conjugates: New angiogenesis inhibitors with antitumor activity in mice. Cancer Res. 55: 3000-3007, 1993.
146. Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H.-J., de Tribolet, N. & Cavenee, W. K.: Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genetics 8: 171-176, 1994.
147. Varner, J. A., Brooks, P. C. & Cheresh, D. A.: The integrin avβ3: Angiogenesis and apoptosis. Cell Adhes. Commun. 3: 367-374, 1995.
148. Vassalli, J.-D., Sappino, A.-P. & Belin, D.: The plasminogen activator/plasmin system. J. Clin. Invest. 88: 1067-1072, 1991.
149. Vukanovic, J. & Isaacs, J. T.: Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res. 55: 1499-1504, 1995.
150. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C. H.: Different signal transduction properties of KDR and Fit-1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269: 26988-26995, 1994.
151. Webb, L. M. C., Ehrengruber, M. U., Clark-Lewis, I., Baggiolini, M. & Rot, A.: Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. 90: 7158-7162, 1993.
152. Weidner, N., Semple, J. P., Welch, W. R. & Folkman, J.: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N. Engl. J. Med. 324: 1-8, 1991.
153. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S. & Gasparini, G.: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer. Inst. 84: 1875-1887, 1992.
154. Weiss, R. R., Whitaker-Menezes, D., Longley, J., Bender, J. & Murphy, G. F.: Human dermal endothelial cells express membrane-associated mast cell growth factor. J. Invest. Dermatol. 104: 101-106, 1995.
155. Weninger, W., Pammer, J., Baghestanian, M., Mildner, M., Uthman, A., Ballaun, C., Bankl, H.-C. & Valent, P.: Expression of vascular endothelial growth factor (VEGF) by human mast cells. J. Vasc. Res. 33: S1, 422, 1996.
156. Wilting, J. & Christ, B.: A morphological study of the rabbit corneal assay. Anat. Ann. 174: 549-556, 1992.
157. Wilting, J. & Christ, B.: Embryonic angiogenesis: A review. Naturwissenschaften 83: 153-164, 1996.
158. 165 and PDGF-BB. Anat. Embryol. 186: 251-257, 1992.
159. Wilting, J., Christ, B., Bokeloh, M. & Weich, H. A.: In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res. 274: 163-172, 1993.
160. 121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of the chorioallantoic membrane. Dev. Biol. 176: 76-85, 1996.
161. Yanagi, K. & Ohshima, N.: Angiogenic vascular growth in the rat peritoneal disseminated tumor model. Microvasc. Res. 51: 15-28, 1996.
162. Yoshiji, H., Gomez, D. E., Shibuya, M. & Thorgeirsson, U. P.: Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res. 56: 2013-2016, 1996.
163. Zauberman, H., Michaelson, I. C., Bergmann, F. & Maurice, D. M.: Stimulation of neovascularization of the cornea by biogenic amines. Exptl. Eye Res. 8: 77-78, 1969.
164. Zhang, Y., Deng, Y., Luther, T., Müller, M., Ziegler, R., Waldherr, R., Stern, D. M. & Nawroth, P. P.: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J. Clin. Invest. 94: 1320-1327, 1994.
165. Ziche, M., Jones, J. & Gullino, P. M.: Role of prostaglandin E1 and copper in angiogenesis. J. Natl. Cancer Inst. 69: 475-482, 1982.